18 FLUODEOXIGLUCOSA EN SOLUCION TAMPONADA (SOLUCIÓN INYECTABLE) Panama - Ingliż - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

18 fluodeoxiglucosa en solucion tamponada (solución inyectable)

radiofarmacia de centroamerica s.a - fluodeoxiglucosa 18 f - fluodeoxiglucosa 18 f....15 mci/0.55 gbq a 3ci/111 gbq en 3 ml a 19 ml

Creon 25,000 New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

creon 25,000

viatris limited - pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.); pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u; pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Roferon-A New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

roferon-a

roche products (nz) ltd - interferon alfa-2a 18 miu - powder for injection - 18 miu - active: interferon alfa-2a 18 miu excipient: albumin sodium chloride water for injection

Roferon-A New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

roferon-a

roche products (nz) ltd - interferon alfa-2a 18 miu/ml;   - solution for injection - 9miu/0.5ml - active: interferon alfa-2a 18 miu/ml   excipient: ammonium acetate benzyl alcohol glacial acetic acid polysorbate 80 sodium chloride sodium hydroxide water for injection - roferon-a is indicated for the treatment of basal cell carcinoma, carcinoid syndrome, chronic lymphocytic leukaemia (early stage), chronic myelogenous leukaemia, , condylomata acuminata, cutaneous t cell lymphoma (mycosis fungoides and sezary syndrome), essential thrombocythaemia, hairy cell leukaemia, kaposi's sarcoma associated with aids, malignant melanoma, multiple myeloma, non-hodgkin's lymphoma (low and intermediate grade), renal cell carcinoma (recurrent or metastatic).

Stalevo New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

stalevo

orion pharma (nz) limited - carbidopa monohydrate 20.25mg equivalent to 18.75 mg carbidopa;  ; entacapone 200mg; levodopa 75mg - film coated tablet - 75mg/18.75mg/200mg - active: carbidopa monohydrate 20.25mg equivalent to 18.75 mg carbidopa   entacapone 200mg levodopa 75mg excipient: croscarmellose sodium ethanol glycerol hypromellose iron oxide red magnesium stearate   maize starch mannitol polysorbate 80 povidone purified water sucrose titanium dioxide - stalevo is indicated for the treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

innohep 18,000 IU in 0.9 ml, solution for injection Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

innohep 18,000 iu in 0.9 ml, solution for injection

leo laboratories limited - tinzaparin sodium - solution for injection - 18,000 iu in 0.9 ml international unit(s)/millilitre - heparin group; tinzaparin

Spiriva 18 microgram inhalation powder, hard capsule Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

spiriva 18 microgram inhalation powder, hard capsule

imed healthcare ltd. - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

Spiriva 18 microgram inhalation powder, hard capsule Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

spiriva 18 microgram inhalation powder, hard capsule

pco manufacturing ltd. - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

Spiriva 18 microgram, inhalation powder, hard capsule Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

spiriva 18 microgram, inhalation powder, hard capsule

imbat limited - tiotropium bromide - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide

Srivasso 18 microgram, inhalation powder, hard capsule Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

srivasso 18 microgram, inhalation powder, hard capsule

boehringer ingelheim international gmbh - tiotropium - inhalation powder, hard capsule - 18 microgram(s) - anticholinergics; tiotropium bromide